A detailed history of Your Advocates Ltd., LLP transactions in Aurinia Pharmaceuticals Inc. stock. As of the latest transaction made, Your Advocates Ltd., LLP holds 200 shares of AUPH stock, worth $1,602. This represents 0.0% of its overall portfolio holdings.

Number of Shares
200
Previous 200 -0.0%
Holding current value
$1,602
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022

SELL
$8.95 - $12.8 $13,424 - $19,200
-1,500 Reduced 88.24%
200 $2,000
Q1 2022

Apr 26, 2022

BUY
$10.05 - $22.48 $15,577 - $34,844
1,550 Added 1033.33%
1,700 $21,000
Q4 2021

Jan 21, 2022

SELL
$17.78 - $33.08 $1,778 - $3,308
-100 Reduced 40.0%
150 $3,000
Q3 2021

Nov 05, 2021

BUY
$10.93 - $23.55 $2,732 - $5,887
250 New
250 $6,000

Others Institutions Holding AUPH

About Aurinia Pharmaceuticals Inc.


  • Ticker AUPH
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,892,000
  • Market Cap $1.14B
  • Description
  • Aurinia Pharmaceuticals Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies to treat various diseases with unmet medical need in the United States and internationally. The company offers LUPKYNIS for the treatment of adult patients with active lupus nephritis. It has a collaboration and license...
More about AUPH
Track This Portfolio

Track Your Advocates Ltd., LLP Portfolio

Follow Your Advocates Ltd., LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Your Advocates Ltd., LLP, based on Form 13F filings with the SEC.

News

Stay updated on Your Advocates Ltd., LLP with notifications on news.